Le Lézard
Classified in: Health
Subject: MRR

Gastroscopes Market to grow by USD 366.84 million from 2022-2027 | North America to account for 40% of market growth - Technavio

NEW YORK, Sept. 26, 2023 /PRNewswire/ -- The gastroscopes market size is expected to grow by USD 366.84 million from 2022 to 2027. In addition, the momentum of the market will progress at a CAGR of 4.85% during the forecast period, according to Technavio Research. The market is segmented by End-user (Hospital, ASCs, and Others), Product (Flexible and Rigid), and Geography (North America, Europe, Asia, and Rest of World (ROW)). North America will contribute 40% to the growth of the global market during the forecast period. It is a key region for the adoption and use of advanced medical technologies such as gastroscopy because of the presence of well-developed and robust healthcare infrastructures in the US and Canada. North America also is a hub for many well-equipped hospitals, clinics, and gastroenterology centers that perform a large number of endoscopic procedures.Such centers use the endoscope to allow gastroenterologists to perform a wide range of diagnostic and therapeutic procedures. Market vendors like Conmed Corp, Stryker Corp, Johnson, and Johnson Services Inc., and Laborie Medical Technologies Corp in the region also boost the market growth during the forecast period. This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Read Free PDF Sample Report

Company Profile:

Advin Health Care, Arthrex Inc., B.Braun SE, Boston Scientific Corp., Carl Zeiss AG, Conmed Corp., Endomed Systems GmbH, FUJIFILM Corp., HOYA Corp., HUGER Medical Instrument Co. Ltd., Johnson and Johnson, KARL STORZ SE and Co. KG, LABORIE MEDICAL TECHNOLOGIES CORP., Medtronic Plc, Mitra Group, Olympus Corp., Richard Wolf GmbH, Smith and Nephew plc, Stryker Corp., dantschke Medizintechnik GmbH and Co. KG

Conmed Corp.: The company offers gastroscope devices such as Biliary and Endoscopic Ultrasound devices.

Gastroscopes Market: Segmentation Analysis

By Segment - The hospital segment will be significant during the forecast period. Hospitals also depend on gastroscopes to perform therapeutic procedures like bleeding ulcers, removing polyps, dilating strictures, and managing other gastrointestinal abnormalities.  Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View Free PDF Sample Report

"Besides analyzing the current market scenario, our report examines historic data from 2017 to 2021"- Technavio

Gastroscopes Market: Driver & Trend:


Increasing incidence of gastrointestinal disorders drives the gastroscopes market. There is a growing prevalence of gastrointestinal disorders such as diverticulosis, intestinal diseases, gastrointestinal malignancies, and urinary and fecal problems. The health care system which experiences a threat from such conditions uses endoscopic procedures for their early detection, effective management, and prevention. These instruments also enable healthcare providers to identify abnormalities, perform biopsies, and perform therapeutic interventions. Hence, such factors drive the growth of the gastroscopes market during the forecast period.

Strategic alliances among market vendors are a key trend in the gastroscopes market. Identify key trends, drivers, and challenges in the market. Download free sample report to gain access to this information.

Related Reports:

The Gastrointestinal  Over-The-Counter (OTC) Drugs Market size is estimated to grow at a CAGR of 5.29% between 2022 and 2027. The market size is forecasted to increase by USD 4,759.86 million.

The gastrointestinal stromal tumors therapeutics market size is expected to increase by USD 1.08 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 5.97%.

What are the key data covered in this gastroscopes market report?


Executive Summary

Market Landscape

Market Sizing

Historic Market Sizes

Five Forces Analysis

Market Segmentation by End-user

Market Segmentation by Product

Market Segmentation by Geography

Customer Landscape

Geographic Landscape

Drivers, Challenges, & Trends

Company Landscape

Company Analysis


About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

SOURCE Technavio

These press releases may also interest you

28 nov 2023
Auna S.A. ("Auna," the "Company" or "we"), one of the largest players in the Latin American healthcare industry and with presence in Mexico, Colombia and Peru, announced today the early participation results of its previously announced offer to...

28 nov 2023
The camphor oil market size is expected to grow by USD 14,787.82 thousand from 2022 to 2027, according to Technavio. In addition, the growth momentum of the market will progress at a CAGR of 3.13% during the forecast period. Growing demand for...

28 nov 2023
Seelos Therapeutics, Inc. ("Seelos"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it has priced its underwritten public offering of...

28 nov 2023
Chula Medicine has designed an anti-choke mug with calculated angle, amount, and time of water flow from the mug to the patient's lips hoping to reduce choking that may lead to lung infection, bring peace of mind to caregivers, and make it safer for...

28 nov 2023
Abstrax, the leader in botanical flavor technology, is thrilled to announce its partnership with Advanced Vapor Devices LLC (AVD), a leader in cannabis vaporizer technology, and McKinney Regulatory Science...

28 nov 2023
Thermo Fisher Scientific Inc. ("Thermo Fisher") announced today that it has priced an offering of $2.5 billion aggregate principal amount (the "Offering") of the following notes: $1.0 billion aggregate principal amount of its 5.000% senior notes...

News published on and distributed by: